Complete versus culprit-only revascularization in patients with multi-vessel disease undergoing primary percutaneous coronary intervention: A meta-analysis of randomized trials

International Journal of Cardiology

Volumn 186, Issue , 2015, Pages 98-103

  Elgendy, Islam Y ^a   Huo, Tianyao ^a   Mahmoud, Ahmed ^a   Bavry, Anthony A ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Multivessel coronary artery disease; Myocardial infarction; Primary percutaneous coronary intervention; Revascularization

Indexed keywords

ALL CAUSE MORTALITY; ARTICLE; BLEEDING; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; FOLLOW UP; HEART FAILURE; HEART INFARCTION; HUMAN; INCIDENCE; META ANALYSIS; MORTALITY; NON FATAL MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVASCULARIZATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SYSTEMATIC REVIEW; HEART MUSCLE REVASCULARIZATION; PREOPERATIVE CARE; PROCEDURES;

CORONARY ARTERY DISEASE; HUMANS; MYOCARDIAL REVASCULARIZATION; PERCUTANEOUS CORONARY INTERVENTION; PREOPERATIVE CARE;

EID: 84929167904     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.03.163     Document Type: Article

References (30)

1. E.C. Keeley, J.A. Boura, and C.L. Grines Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials Lancet 361 2003 13 20
2. T. Huynh, S. Perron, and J. O'Loughlin Comparison of primary percutaneous coronary intervention and fibrinolytic therapy in ST-segment-elevation myocardial infarction: Bayesian hierarchical meta-analyses of randomized controlled trials and observational studies Circulation 119 2009 3101 3109
3. P. Sorajja, B.J. Gersh, and D.A. Cox Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction Eur. Heart J. 28 2007 1709 1716
4. M. Toma, C.E. Buller, and C.M. Westerhout Non-culprit coronary artery percutaneous coronary intervention during acute ST-segment elevation myocardial infarction: insights from the APEX-AMI trial Eur. Heart J. 31 2010 1701 1707
5. P.T. O'Gara, F.G. Kushner, and D.D. Ascheim 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J. Am. Coll. Cardiol. 61 4 2013 e78 e140
6. P.G. Steg, S.K. James, and D. Atar ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation Eur. Heart J. 33 2012 2569 2619
7. E.L. Hannan, Z. Samadashvili, and G. Walford Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease J. Am. Coll. Cardiol. Intv. 3 2010 22 31
8. D. Qarawani, M. Nahir, M. Abboud, Y. Hazanov, and Y. Hasin Culprit only versus complete coronary revascularization during primary PCI Int. J. Cardiol. 123 2008 288 292
9. R. Kornowski, R. Mehran, and G. Dangas Prognostic impact of staged versus "one-time" multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial J. Am. Coll. Cardiol. 58 2011 704 711
10. A.A. Khattab, M. Abdel-Wahab, and C. Röther Multi-vessel stenting during primary percutaneous coronary intervention for acute myocardial infarction: a single-center experience Clin. Res. Cardiol. 97 2008 32 38
11. A.H. Gershlick Managing multi-vessel disease detected at P-PCI for STEMI: the Complete versus Lesion-only PRimary PCI Trial (CvLPRIT) Presented at the European Society of Cardiology Scientific Sessions, Barcelona, Spain 2014 (September 1)
12. D.S. Wald, J.K. Morris, and N.J. Wald Randomized trial of preventive angioplasty in myocardial infarction N. Engl. J. Med. 369 2013 1115 1123
13. R. DerSimonian, and N. Laird Meta-analysis in clinical trials Control. Clin. Trials 7 1986 177 188
14. N. Mantel, and W. Haenszel Statistical aspects of the analysis of data from retrospective studies of disease J. Natl. Cancer Inst. 22 1959 719 748
15. J.P. Higgins, S.G. Thompson, J.J. Deeks, and D.G. Altman Measuring inconsistency in meta-analyses BMJ 327 2003 557 560
16. M. Egger, G. Davey Smith, M. Schneider, and C. Minder Bias in meta-analysis detected by a simple, graphical test BMJ 315 1997 629 634
17. D. Moher, A. Liberati, J. Tetzlaff, D.G. Altman, and PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement BMJ 339 2009 b2535
18. P. Juni, D.G. Altman, and M. Egger Systematic reviews in health care: assessing the quality of controlled clinical trials BMJ 323 2001 42 46
19. A. Ghani, J.H. Dambrink, A.W. van 't Hof, J.P. Ottervanger, A.T. Gosselink, and J.C. Hoorntje Treatment of non-culprit lesions detected during primary PCI: long-term follow-up of a randomised clinical trial Neth. Heart J. 20 2012 347 353
20. L. Politi, F. Sgura, and R. Rossi A randomised trial of target-vessel versus multi-vessel revascularisation in ST-elevation myocardial infarction: major adverse cardiac events during long-term follow-up Heart 96 2010 662 667
21. C. Di Mario, S. Mara, and A. Flavio Single vs multivessel treatment during primary angioplasty: results of the multicentre randomised HEpacoat for cuLPrit or multivessel stenting for Acute Myocardial Infarction (HELP AMI) Study Int. J. Cardiovasc. Intervent. 6 2004 128 133
22. A. Ochala, G.A. Smolka, and W. Wojakowski The function of the left ventricle after complete multivessel one-stage percutaneous coronary intervention in patients with acute myocardial infarction J. Invasive Cardiol. 16 2004 699 702
23. F. Cuculi, G.L. De Maria, and P. Meier Impact of microvascular obstruction on the assessment of coronary flow reserve, index of microcirculatory resistance, and fractional flow reserve after ST-segment elevation myocardial infarction J. Am. Coll. Cardiol. 64 2014 1894 1904
24. M. Shamir Complete vs Culprit-only Revascularization to Treat Multi-vessel Disease After Primary PCI for STEMI clinicaltrials.gov [Internet] 2000 National Library of Medicine (US) Bethesda (MD) ([cited 2014 Oct 29]. Available from: http://clinicaltrials.gov/show/ NCT01740479 NLM Identifier: NCT01740479)
25. P.J. Vlaar, K.D. Mahmoud, and D.R. Holmes Jr. Culprit vessel only versus multivessel and staged percutaneous coronary intervention for multivessel disease in patients presenting with ST-segment elevation myocardial infarction: a pairwise and network meta-analysis J. Am. Coll. Cardiol. 58 2011 692 703
26. K.R. Bainey, S.R. Mehta, T. Lai, and R.C. Welsh Complete vs culprit-only revascularization for patients with multivessel disease undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a systematic review and meta-analysis Am. Heart J. 167 2014 1 14
27. N. Sekercioglu, F.A. Spencer, L. Cruz Lopes, and G.H. Guyatt Culprit vessel only vs immediate complete revascularization in patients with acute ST-segment elevation myocardial infarction: systematic review and meta-analysis Clin. Cardiol. 37 2014 765 772
28. J.J. Rade FFR-guided PCI-FAME may not be so fleeting after all N. Engl. J. Med. 371 2014 1251 1253
29. M.S. Chen, J.M. John, D.P. Chew, D.S. Lee, S.G. Ellis, and D.L. Bhatt Bare metal stent restenosis is not a benign clinical entity Am. Heart J. 151 2006 1260 1264
30. A.A. Bavry, and D.L. Bhatt Appropriate use of drug-eluting stents: balancing the reduction in restenosis with the concern of late thrombosis Lancet 371 2008 2134 2143 (Erratum, Lancet. 2008; 372:536.)